Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Head and neck cancer Stories

2012-07-20 01:48:35

Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with throat cancer, say Henry Ford Hospital researchers. According to their new study, HPV has a substantial impact on overall survival in African Americans with oropharyngeal cancer, a cancer that affects part of the throat, the base of the tongue, the tonsils, the soft palate (back of the mouth),...

2012-07-18 12:09:39

More children are surviving cancer in Britain than ever before according to new research published in the cancer journal Annals of Oncology today (Wednesday). The improvement in survival has been driven by the increasing numbers taking part in clinical trials since 1977 when the UK Children's Cancer Study Group (UKCCSG) was established. The UKCCSG's principal aim was to set up a comprehensive portfolio of national and international trials for the majority of children's cancers. As result,...

2012-06-28 02:28:08

DALLAS and NEW YORK, June 28, 2012 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.(OTCBB: ACCP), a biopharmaceutical company developing treatments in areas of oncology and oncology supportive care, announced that Dr. Ron R. Allison of Carolina Radiation Medicine, Greenville, NC, presented results from its ongoing MuGard Phase 4 clinical trial in oral mucositis (OM) at the Multinational Association of Supportive Care in Cancer (MASCC) Conference in New York City. The presentation summarized data...

2012-06-26 06:20:45

(Ivanhoe Newswire) -- According to the National Cancer Institute, there has been a steady increase in the prevalence of oropharyngeal cancers in the U.S. since 1973. Researchers believe this increase has mainly been attributed to oral HPV infection. A new study attempts to show links between gum disease and HPV to head and neck cancers. Researchers at the University at Buffalo School of Dental Medicine evaluated data from 124 patients diagnosed with primary head and neck squamous cell...

2012-06-21 02:26:13

CALGARY, June 21, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that it has entered into an agreement whereby the NCIC Clinical Trials Group (NCIC CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN(®) in patients with advanced or metastatic breast cancer. "We are excited to announce our fourth randomized study with the NCIC CTG," said Dr. Brad Thompson, President...

2012-06-20 02:26:31

CALGARY, June 20, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX: ONC) NASDAQ: ONCY) announced today that the Company's independent Data Monitoring Committee (DMC) has reviewed the safety data for the first stage of its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018). Based on the review of the safety data the DMC has recommended that enrollment continue in the study. "The safety data...

2012-06-19 09:35:08

Among patients with head and neck squamous cell carcinomas, a history of chronic inflammation in the mouth (periodontitis, i.e. gum disease) may be associated with an increased risk of tumors positive for human papillomavirus (HPV), according to a report published Online First by Archives of Otolaryngology — Head & Neck Surgery, a JAMA Network publication. The National Cancer Institute has reported a steady increase in the prevalence of oropharyngeal cancers in the United States...

2012-06-13 10:23:48

CALGARY, June 13, 2012 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that a paper entitled "Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients," has been published in the latest issue of the journal Science Translational Medicine (Vol. 4 Issue 138 138ra77). The paper covers findings from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in...

2012-06-12 10:35:09

Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to an article published in the June 2012 issue of Otolaryngology—Head and Neck Surgery. "Submental lymphedema is a common problem encountered by patients following treatment of head and neck cancer," the authors state. It causes fluid deposition and persistent swelling of the soft tissues of the neck, leading to...

New Drug Shows Significant Results In Rare Skin Cancer Treatment
2012-06-07 13:05:19

Doctors charged with treating patients with a rare form of one of the most common types of cancer in the US may have a new weapon for their fight after a clinical study has shown a particular drug has proven very effective in both the treatment and prevention of the disease. The new drug, vismodegib (or Erivedge), has been found to dramatically shrink basal cell carcinoma (BCC) skin cancers and prevent the formation of new ones in patients with basal cell nevus syndrome (BCNS), or Gorlin...